TLTianhua Li

Tianhua Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tianhua Li has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Futao Hu

    The faculty of marine, Ningbo University, Ningbo 315211, China

    1 shared publication
  • Guangming Song

    Department of Anesthesiology Dongying People's Hospital Dongying Shandong China

    1 shared publication
  • Hankun Zhou

    The State Key Laboratory Base of Novel Functional Materials and Preparation Science, Faculty of Material Science and Chemical Engineering, Ningbo University, Ningbo 315211, China

    1 shared publication
  • Huijie Yu

    Department of Critical Care, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    1 shared publication
  • Jinshan Liu

    Department of Anesthesiology Dongying People's Hospital Dongying Shandong China

    1 shared publication
  • Kun Wang

    Department of Operating Room Dongying People's Hospital Dongying Shandong China

    1 shared publication

Latest Publications

  • Open Access

    The expression and biological function of DKK1 in oral squamous cell carcinomas by bioinformatics analysis

    by Huijie Yu, Tianhua Li, Xuemei Mao

    Objective: To clear the expression of transcription factor Dickkopf-1 (DKK1) in Oral Squamous Cell Carcinoma (OSCC) using the method of bioinformatics analysis. And to clarify the relationship between the expression of DKK1 and the clinicopathological characteristics of OSCC using the method of molecular biology and cytobiology, in order to determine the early diagnosis and significance of OSCC according to the marker of DKK1. Methods: In this study, the expression level of DKK1 in OSCC tissues was analyzed using GEPIA and TCGA databases, and then verified in vitro by qRT-PCR and Western-blot analysis. The correlation between DKK1 gene expression and the clinical pathological parameters of OSCC, and also the impact of DKK1 on prognosis were determined using the Linked Omics database. In addition, DKK1 was knocked down by RNA interference in SCC-4 and SCC-25 OSCC cell lines and the proliferation ability of OSCC cells was assessed by MTT assay. Results: High expression of DKK1 in OSCC is positively correlated with the pathological grade and T stage of OSCC. According to the TCGA results, DKK1 mRNA was highly expressed and it is related to the overall survival rate of OSCC. In addition, the expression level of both DKK1mRNA and protein were significantly raised in the cell line SCC25 and SCC-4. Furthermore, MTT analysis showed that DKK1 knockdown resulted in reduced proliferation of OSCC cells. Conclusions: TCGA database analysis showed that DKK1 was highly expressed in OSCC, and it is closely correlated to the pathological parameters of OSCC, which will provide important theoretical guidance for the subsequent study of oral squamous cell carcinoma.

  • Antitumor activity of sevoflurane in HCC cell line is mediated by miR‐29a‐induced suppression of Dnmt3a

    by Guangming Song, Ling Tian, Yi Cheng, Jinshan Liu, Kun Wang, Shuai Li, Tianhua Li

    Sevoflurane (SEVO) is widely applied as an anesthetic. More recently, its antitumor capacity has been reported. However, potent mechanisms are still incompletely ascertained. In our current study, we attempted to elucidate a potent mechanism associated with microRNA (miR)‐29a/DNA methyltransferase 3 alpha (Dnmt3a) in hepatocellular carcinoma (HCC) cells. After transfection and stimulation with SEVO, biological activities of Huh7 and HepG2 cells were evaluated using the cell counting kit‐8, Annexin V‐fluorescein isothiocyanate apoptosis detection kit, 24‐well cell migration assay kit, and tumor invasion 24‐well plates. miR‐29a and protein expression were quantified with quantitative reverse transcription polymerase chain reaction and Western blot assay, respectively. A Dual‐Luciferase Reporter Assay System was used to verify whether miR‐29a targets Dnmt3a. We found that SEVO alleviated cell viability, aggrandized apoptosis, and impeded migration and invasion of the Huh7 and HepG2 cells. Besides, SEVO enhanced phosphatase and tensin homolog (PTEN) expression, and phosphorylated expression of phosphatidylinositol 3 kinase (PI3K), and protein kinase B (AKT) was eliminated by SEVO. Of note, SEVO restored miR‐29a which was downregulated in HCC tissues and cells. miR‐29a inhibitor abolished the positive effects of SEVO on the biological processes. Dual‐Luciferase Reporter assay showed miR‐29a repressed Dnmt3a expression via targeting its 3′‐untranslated region. Further, exogenous expression of Dnmt3a partially repressed PTEN and enhanced phosphorylated expression of PI3K and AKT which were originally elevated or diminished by SEVO. In conclusion, SEVO restored the expression of miR‐29a, which posttranscriptionally downregulated Dnmt3a, and then exhibited an antitumor property in HCC cells.